Inventor · disambiguated record
Christoph Esslinger
Also filed as: ESSLINGER CHRISTOPH
9 granted patents·14 pending applications·77 citations·filing 2008–2023
87Inventor score
Top patents by PatentIndex Score
23 records- 0195US9828420B2Method of providing disease-specific binding molecules and targetsUNIV ZUERICH·Filed 2016·Granted Nov 28, 2017·14 cites·22 claims
- 0292US10202445B2Method of providing disease-specific binding molecules and targetsUNIV ZUERICH·Filed 2017·Granted Feb 12, 2019·7 cites·13 claims
- 0391US10131708B2Methods of treating Alzheimer's diseaseUNIV OF ZUERICH·Filed 2017·Granted Nov 20, 2018·12 cites·88 claims
- 0491US8906367B2Method of providing disease-specific binding molecules and targetsNITSCH ROGER·Filed 2008·Granted Dec 9, 2014·29 cites·21 claims
- 0589US9670272B2Method of providing disease-specific binding molecules and targetsUNIV OF ZÜRICH·Filed 2012·Granted Jun 6, 2017·14 cites·10 claims
- 0677US2022403011A1Method of providing disease-specific binding molecules and targetsUNIV OF ZUERICH·Filed 2022·Application pending·0 cites
- 0770US2019153082A1Method of providing disease-specific binding molecules and targetsUNIV ZUERICH·Filed 2018·Application pending·0 cites
- 0866US11976276B2Method for recovering two or more genes, or gene products, encoding an immunoreceptorMEMO THERAPEUTICS AG·Filed 2021·Granted May 7, 2024·0 cites·18 claims
- 0966US2019263896A1Method of providing disease-specific binding molecules and targetsUNIV OF ZUERICH·Filed 2018·Application pending·0 cites
- 1065US2015147343A1Method of providing disease-specific binding molecules and targetsNITSCH ROGER·Filed 2014·Application pending·0 cites
- 1164US2013266585A1Method of Providing Disease-Specific Binding Molecules and TargetsUNIV ZUERICH·Filed 2013·Application pending·0 cites
- 1264US2013266586A1Method of Providing Disease-Specific Binding Molecules and TargetsUNIV ZUERICH·Filed 2013·Application pending·0 cites
- 1364US2013266514A1Method of Providing Disease-Specific Binding Molecules and TargetsUNIV ZUERICH·Filed 2013·Application pending·0 cites
- 1464US2024228590A9Anti-bk virus antibody moleculesMEMO THERAPEUTICS AG·Filed 2023·Application pending·0 cites
- 1562US11919943B2Anti-BK virus antibody moleculesMEMO THERAPEUTICS AG·Filed 2022·Granted Mar 5, 2024·0 cites·16 claims
- 1659US2018353603A1Combination therapy including tumor associated antigen binding antibodiesCT ATLANTIC LTD·Filed 2018·Application pending·0 cites
- 1756US8519106B2Monoclonal human tumor-specific antibodyESSLINGER CHRISTOPH·Filed 2008·Granted Aug 27, 2013·1 cites·14 claims
- 1848US2023009582A1Anti-siglec-9 antibody moleculesMEMO THERAPEUTICS AG·Filed 2020·Application pending·0 cites
- 1945US2011171688A1Method of providing immunoglobulin secreting b lymphocytes and human antibodiesESSLINGER CHRISTOPH·Filed 2009·Application pending·0 cites
- 2044US2013295091A1Combination therapy including tumor associated antigen binding antibodiesESSLINGER CHRISTOPH·Filed 2012·Application pending·0 cites
- 2143US11312952B2Method for recovering two or more genes, or gene products, encoding an immunoreceptorMEMO THERAPEUTICS AG·Filed 2015·Granted Apr 26, 2022·0 cites·13 claims
- 2235US2014093514A1Magea3 binding antibodiesESSLINGER CHRISTOPH·Filed 2012·Application pending·0 cites
- 2335US2014186363A1Magea3 binding antibodiesESSLINGER CHRISTOPH·Filed 2012·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →